Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Pfanstiel Steven, Chief Financial Officer. Officer active across 3 companies, notably Marinus Pharmaceuticals INC. Aggregated, 14 filings have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €77k. Activity tracked since 4 February 2022. The latest transaction was disclosed on 19 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations
Pfanstiel Steven is Directeur Financier. The record shows 14 filings in total. Across the 14 most recent sampled filings, there were only sales, for a total of EUR 85977, over the period from 2022-02-07 to 2026-03-24. The companies mentioned are Marinus Pharmaceuticals, INC., Marinus Pharmaceuticals INC and Neuronetics, Inc., and the modal transaction nature is Attribution.